Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study

The NeuroNEXT Clinical Trial Network and on behalf of the NN101 SMA Biomarker Investigators

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint Dive into the research topics of 'Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study'. Together they form a unique fingerprint.

Medicine & Life Sciences